Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms
- PMID: 34887571
- PMCID: PMC8656440
- DOI: 10.1038/s41569-021-00662-w
Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms
Erratum in
-
Author Correction: Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms.Nat Rev Cardiol. 2023 Aug;20(8):575. doi: 10.1038/s41569-023-00904-z. Nat Rev Cardiol. 2023. PMID: 37344581 Free PMC article. No abstract available.
Abstract
The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is rare and usually resolves within days or weeks. Moreover, the risks of hospitalization and death associated with COVID-19 are greater than the risk associated with COVID-19 vaccination. Therefore, COVID-19 vaccination should be recommended in adolescents and adults.
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.JAMA. 2022 May 24;327(20):2019-2020. doi: 10.1001/jama.2022.5131. JAMA. 2022. PMID: 35608592 No abstract available.
-
Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.JAMA. 2022 May 24;327(20):2020-2021. doi: 10.1001/jama.2022.5134. JAMA. 2022. PMID: 35608588 No abstract available.
-
Features of Inflammatory Heart Reactions Following mRNA COVID-19 Vaccination at a Global Level.Clin Pharmacol Ther. 2022 Mar;111(3):605-613. doi: 10.1002/cpt.2499. Epub 2021 Dec 27. Clin Pharmacol Ther. 2022. PMID: 34860360 Free PMC article.
-
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.BMJ. 2022 Jul 13;378:e069445. doi: 10.1136/bmj-2021-069445. BMJ. 2022. PMID: 35830976 Free PMC article. Review.
-
Incidence, Clinical Presentation, and Management of Myocarditis following mRNA-Based Covid-19 Vaccines: A Brief Report.Cardiology. 2022;147(4):406-412. doi: 10.1159/000522216. Epub 2022 Feb 1. Cardiology. 2022. PMID: 35104821 Free PMC article. Review.
Cited by
-
Serious adverse events following immunization with COVID-19 vaccines in Lebanon: a retrospective analysis of the National Pharmacovigilance Database.BMC Public Health. 2024 Oct 21;24(1):2905. doi: 10.1186/s12889-024-20297-z. BMC Public Health. 2024. PMID: 39434043 Free PMC article.
-
COVID-19 Vaccine: A Potential Risk Factor for Accelerating the Onset of Bullous Pemphigoid.Vaccines (Basel). 2024 Sep 5;12(9):1016. doi: 10.3390/vaccines12091016. Vaccines (Basel). 2024. PMID: 39340046 Free PMC article.
-
Endurance Exercise Does Not Exacerbate Cardiac Inflammation in BALB/c Mice Following mRNA COVID-19 Vaccination.Vaccines (Basel). 2024 Aug 26;12(9):966. doi: 10.3390/vaccines12090966. Vaccines (Basel). 2024. PMID: 39339998 Free PMC article.
-
Cardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA: longitudinal results from the Myocarditis After COVID Vaccination (MACiV) multicenter study.EClinicalMedicine. 2024 Sep 6;76:102809. doi: 10.1016/j.eclinm.2024.102809. eCollection 2024 Oct. EClinicalMedicine. 2024. PMID: 39290640 Free PMC article.
-
Vaccines for Respiratory Viruses-COVID and Beyond.Vaccines (Basel). 2024 Aug 22;12(8):936. doi: 10.3390/vaccines12080936. Vaccines (Basel). 2024. PMID: 39204059 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
